# Drug Study of Albuterol to Treat Acute Lung Injury

> **NCT00434993** · PHASE2,PHASE3 · TERMINATED · sponsor: **National Heart, Lung, and Blood Institute (NHLBI)** · enrollment: 282 (actual)

## Conditions studied

- Respiratory Distress Syndrome, Adult

## Interventions

- **DRUG:** Albuterol Sulfate
- **PROCEDURE:** Mini-Bronchoalveolar Lavage (BAL)
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT00434993
- **Lead sponsor:** National Heart, Lung, and Blood Institute (NHLBI)
- **Sponsor class:** NIH
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2007-08
- **Primary completion:** 2008-09
- **Final completion:** 2008-11
- **Target enrollment:** 282 (ACTUAL)
- **Why stopped:** Stopped for futility by DSMB
- **Last updated:** 2017-02-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00434993

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00434993, "Drug Study of Albuterol to Treat Acute Lung Injury". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT00434993. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*